IndexIQ Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

IndexIQ Advisors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$412K	Buy	+9,988	New	+$352K	0.01%	518

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

IndexIQ Advisors's SILK Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Silk Road Medical, Inc. Common Stock (SILK) in Q1 2022: 9,988 shares worth $412K. The stake represents 0.01% of the portfolio and ranks #518 among its holdings.

153 funds tracked by Wall St. Rank hold SILK as of Q1 2022.

IndexIQ Advisors held 9,988 shares of Silk Road Medical, Inc. Common Stock worth $412K as of Q1 2022.
Silk Road Medical, Inc. Common Stock was a new IndexIQ Advisors position in Q1 2022.
Silk Road Medical, Inc. Common Stock made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #518 holding.
153 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.